Dosing interval optimization and persistence with faricimab in age-related macular degeneration: An observational study in real-world clinical practice
Faricimab showed excellent persistence and extended dosing intervals in real-world practice. This is the first study specifically evaluating faricimab real-world persistence in nAMD.
Authors
- Silvia Cornejo
- Alejandro Valcuende-Rosique
- Joaquín Borrás-Blasco
- Virginia Merino
- Leonor Perez Gil
- Nuria Monteagudo-Martinez
Institutions
- Hospital de Sagunto (ES)
Publication Details
- Journal
- Farmacia Hospitalaria
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1016/j.farma.2025.12.002
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00